The case is striking not only because of the dramatic recovery but also because of the therapeutic history that preceded it. The patient had been treated with a proton pump inhibitor, a class of acid-suppressing drugs used by millions of people worldwide for reflux and ulcer disease, as well as with metformin, the first-line medication for type 2 diabetes. Both drugs are increasingly recognized as causes of magnesium depletion. Proton pump inhibitors interfere with intestinal magnesium absorption, while metformin has been linked to urinary magnesium losses in patients with diabetes. The Belgian authors note that their patient had also experienced unexplained transient neurological deficits in the past, episodes that now appear, in retrospect, to have been heralds of the same underlying electrolyte disturbance.

Magnesium is the fourth most abundant cation in the body and the second most abundant inside cells, and its physiological reach is enormous. It serves as a cofactor for hundreds of enzymatic reactions, stabilizes the electrical gradients of excitable membranes, regulates calcium channels, and modulates the release of neurotransmitters at both central and peripheral synapses. Because roughly two thirds of body magnesium is stored in bone and only a tiny fraction circulates in the plasma, the serum level is an imperfect window into total body stores. This biochemical reality helps explain why hypomagnesemia is frequently overlooked: clinicians may assume that a normal-looking electrolyte panel excludes deficiency, or simply never order the measurement at all during the chaotic early minutes of a suspected stroke.

The neurological consequences of magnesium depletion are well documented in other contexts. Low magnesium lowers the seizure threshold, produces tremor, muscle cramps, and tetany, and can cause characteristic eye-movement abnormalities and ataxia. Severe cases have even produced reversible cerebellar syndrome with brain imaging showing swelling of the cerebellum, a phenomenon described in several case reports over the past decade. What has been far rarer in the literature is the attribution of focal deficits, weakness or speech disturbance confined to one side of the body in a pattern that strongly suggests a localized brain lesion, to magnesium deficiency alone. The Belgian team argues that this rarity is at least partly an artifact of under-testing rather than a true biological rarity.

The mechanisms by which magnesium depletion could produce focal symptoms are biologically plausible. Experimental work on cerebral penetrating arterioles has shown that magnesium promotes vasodilation in these small vessels, so its absence may impair the fine regulation of blood flow in deep brain regions. Magnesium also acts as a natural antagonist of the NMDA receptor, damping excitotoxic cascades that amplify injury during ischemia, and clinical studies in patients with aneurysmal subarachnoid hemorrhage have explored magnesium infusions as a protective agent during episodes of critical perfusion. In a deficient state, the loss of these protective functions could render vulnerable brain circuits transiently dysfunctional, producing deficits that mimic vascular occlusion but reverse when the electrolyte balance is restored.

Stroke mimics are far from a marginal concern in emergency neurology. Large registries of patients referred to stroke services have found that a substantial proportion of code-stroke activations ultimately receive a non-ischemic diagnosis, ranging from seizures and migraines to metabolic derangements and functional disorders. Distinguishing true stroke from mimic is one of the hardest tasks in acute medicine, because the cost of missing a real infarct is measured in dead brain tissue, while the cost of treating a mimic with thrombolytics includes potentially catastrophic bleeding. Imaging tools such as CT perfusion have improved this discrimination, but they depend on recognizing which metabolic conditions can distort the pictures they produce. A severe electrolyte abnormality that resolves with repletion belongs firmly on that list.

The literature review accompanying the Belgian case assembles the scattered evidence that severe hypomagnesemia can indeed present as an acute stroke. Earlier reports have described patients in emergency settings and in rehabilitation units whose hemiparesis and aphasia cleared after magnesium replacement, and a 2025 review in Neurological Sciences explicitly asked whether hypomagnesemia is a rare but overlooked stroke mimic. The pattern across these reports is consistent: the patients often carry risk factors for magnesium wasting, such as proton pump inhibitor use, diuretics, alcohol use, diabetes, or diarrhea, and their deficits improve as the serum level normalizes, a trajectory that would be unusual for a completed infarct. The authors of the new report emphasize that despite this documentation, magnesium levels are rarely measured during the acute phase of a suspected stroke.

Why does this gap persist? Part of the answer lies in the historical organization of emergency testing. A classic study from 1990 found that when serum magnesium was measured routinely rather than only when specifically requested, previously unrecognized hypomagnesemia was detected at a meaningful rate, suggesting that clinicians systematically underestimate its prevalence. Magnesium also interacts closely with potassium homeostasis, so refractory hypokalemia is a well-known clue to coexisting magnesium depletion, yet this teaching point competes with dozens of others in crowded emergency protocols. In the hyperacute stroke pathway, where every additional test is weighed against the clock, magnesium has simply never earned a place on the mandatory panel. The Belgian authors argue that the case they present, together with the accumulating literature, makes a compelling case for changing that practice.

The clinical implications are considerable. For patients on proton pump inhibitors and metformin, the combination seen in this case, the possibility of drug-induced magnesium wasting deserves explicit attention whenever neurological symptoms appear, particularly if the deficits fluctuate or if vascular imaging fails to show an occlusion. For stroke teams, the report suggests that a serum magnesium level, a cheap and rapid assay available in virtually every hospital laboratory, could be added to the initial workup of suspected stroke without meaningfully delaying treatment. Identifying a reversible metabolic mimic before administering thrombolytic drugs would spare patients an unnecessary bleeding risk, and correcting the deficiency could resolve deficits that would otherwise trigger days of admission, monitoring, and secondary stroke workup aimed at a vascular cause that does not exist.

The Belgian case report, approved by the ethics committee of the Hopital Civil Marie Curie in Charleroi and published with the patient’s informed consent, is unlikely to overturn stroke care on its own. But it adds a vivid data point to a quiet shift in neurological thinking: that the electrolyte milieu of the brain is not a background variable but an active determinant of focal function. As the authors and their predecessors in the literature suggest, some of the deficits long assumed to be vascular may instead be the nervous system’s distress signal when a critical mineral runs out. For a condition whose treatment is as simple as magnesium repletion, overlooking it is a luxury that emergency medicine can no longer afford.

Subject of Research: Severe hypomagnesemia as a reversible stroke mimic causing focal neurological deficits

Article Title: Stroke mimic caused by severe hypomagnesemia: a case report and literature review

Article References: Vidal Bankier, D., Renard, F., & Manto, M. (2026). Stroke mimic caused by severe hypomagnesemia: a case report and literature review. Journal of Neurology, 273(10), Article 632. https://doi.org/10.1007/s00415-026-14155-8

Image Credits: AI Generated

DOI: 10.1007/s00415-026-14155-8

Keywords: hypomagnesemia, stroke mimic, magnesium, neurology, proton pump inhibitors, metformin, aphasia, hemiparesis, emergency medicine, electrolytes, case report, Journal of Neurology

Weisenburg’s most cited early achievement came in 1910, when he published in the Journal of the American Medical Association a detailed case report of a cerebello-pontile tumor that had been misdiagnosed for six years as tic douloureux, the severe facial pain syndrome now more commonly called trigeminal neuralgia. The case was remarkable not only for its diagnostic detective work but for its systematic description of irritation symptoms affecting the ninth and twelfth cranial nerves, the glossopharyngeal and hypoglossal. By carefully correlating the patient’s paroxysmal pain in the throat and tongue regions with the anatomical course of these nerves, Weisenburg effectively provided one of the earliest clinical characterizations of glossopharyngeal neuralgia, an entity that later reviewers would trace directly back to his report. The lesson he drew, that structural lesions of the posterior fossa can masquerade for years as functional pain syndromes, remains embedded in modern differential diagnosis.

That paper illustrated a methodological habit that defined Weisenburg’s entire career: an insistence that clinical observation be anchored in meticulous anatomical correlation and, wherever possible, quantitative comparison. His interest in localization did not stop at the cranial nerves. In 1927 he contributed to a symposium on the cerebellum in the journal Brain, presenting an extended analysis of cerebellar localization and its symptomatology. At a time when the cerebellum was still often treated as a black box concerned vaguely with coordination, Weisenburg synthesized the available physiological and pathological evidence to argue for a more differentiated map of cerebellar function, connecting specific symptom complexes to specific cerebellar regions. The symposium paper became a reference point for subsequent work on cerebellar signs, including the subtleties of dyssynergia, dysmetria and the variability of clinical expression in cerebellar disease.

Yet it is in the study of aphasia, the devastating loss or impairment of language following brain injury, that Weisenburg made his most enduring scientific mark. In the late 1920s and early 1930s he directed an ambitious research program on language disorders, culminating in the Charles K. Mills memorial lecture delivered before the Philadelphia Neurological Society and published in 1934 in the Archives of Neurology and Psychiatry under the title A Study of Aphasia. The lecture was not a single case report but a synthesis of a large, systematically assembled series of aphasic patients, examined with a battery of tests that Weisenburg and his collaborators designed to probe language function along multiple dimensions: comprehension, repetition, naming, reading and writing. He had presented an early version of this testing framework at the First International Neurological Congress in Berne in 1931, where he also reported on the status of neurology in the United States, signaling his dual commitment to research infrastructure and scientific measurement.

What made the aphasia work genuinely innovative was its insistence on the study of normals. In a 1929 paper in the Journal of the American Medical Association, Weisenburg argued that no account of pathological language could be interpreted correctly without a rigorous description of normal variation in linguistic and intellectual ability across the healthy population. This was a strikingly modern methodological position, decades before the formalization of standardized neuropsychological norms. His group tested control subjects on the same instruments applied to aphasic patients, allowing deficits to be measured against the actual distribution of intact performance rather than against idealized expectations. Contemporary historians of neuropsychology have noted that this concern with defining the normal baseline, and the methodological puzzles it raised about intelligence testing in brain-damaged populations, anticipated debates that continue in the literature on aphasia assessment to this day.

The Mills memorial lecture, published in the opening issue of the Archives of Neurology and Psychiatry for 1934, condensed this program into thirty-three pages that ran counter to the rigid classification schemes then dominant in aphasiology. Weisenburg emphasized the heterogeneity of aphasic syndromes and the partial dissociations among language modalities, resisting the temptation to force every patient into a small number of canonical categories. His quantitative, multi-dimensional approach foreshadowed the psychometric tradition that would later flourish in mid-century neuropsychology, and his collaborators carried the framework forward after his death. In an era when much of aphasiology was fought out between anatomical reductionists and holistic skeptics, Weisenburg’s data-driven middle path proved remarkably prescient.

Weisenburg was also a builder of institutions. He served as editor of the Archives of Neurology and Psychiatry, one of the leading neurological journals in the English-speaking world, shaping the publication record of American neurology during a period of rapid growth. A poignant artifact of that role survives in the Wilder Penfield Digital Collection at McGill: a letter typed on Archives of Neurology and Psychiatry publication office letterhead, dated February 20, 1934, addressed to Wilder Penfield, the pioneering neurosurgeon then transforming the surgical treatment of epilepsy in Montreal. The letter, written just months before Weisenburg’s death, captures the network of correspondence through which the leading neurologists and neurosurgeons of the era exchanged findings, manuscripts and professional judgments. Triarhou’s profile uses such archival traces to situate Weisenburg not as an isolated genius but as a node in a dense transatlantic scientific community that included Penfield, Tilney, McConnell and the heirs of Charles K. Mills.

The circumstances of his death at fifty-eight prompted immediate tributes from colleagues. Frederick Tilney, the Columbia neurologist and himself a distinguished scholar, authored an obituary in the Archives of Neurology and Psychiatry spanning pages 842 to 849 of volume 32, a length that testifies to the esteem in which Weisenburg was held. James McConnell published a parallel memorial in the Journal of Nervous and Mental Disease. Both accounts portray a clinician of unusual diagnostic acuity, a demanding but generous teacher and a researcher who elevated the evidentiary standards of his specialty. Their combined testimony, mined anew by Triarhou, offers modern readers a portrait of what academic neurology looked like in the United States between the world wars: small departments, personal correspondence networks, journals that doubled as scientific forums and a growing awareness that neurology needed its own rigorous psychology.

The reappraisal of Weisenburg’s career comes at a moment when several of his themes have returned to prominence. The study of healthy control populations as an essential complement to patient research, the multidimensional assessment of language, and the careful anatomical dissection of cranial nerve syndromes are all live issues in contemporary neuroscience and neurology. Glossopharyngeal neuralgia, first given clinical definition in his 1910 report, is now routinely treated with microvascular decompression procedures of the kind Penfield’s generation helped to pioneer. Aphasia testing, descendants of whose logic appear in modern standardized batteries, remains central to stroke rehabilitation. And the cerebellum, whose functional organization Weisenburg helped to clarify, has re-emerged as a major focus of research into cognition as well as movement. Triarhou’s profile, published as volume 273, article number 614 of the Journal of Neurology, thus does more than commemorate an anniversary; it demonstrates how the methodological instincts of an early twentieth-century clinician, his demand for baselines, his suspicion of tidy categories and his fusion of bedside observation with quantitative test data, continue to define good practice nearly a century later.

Subject of Research: Historical profile of neurologist Theodore H. Weisenburg and his contributions to aphasia research, cerebellar symptomatology and cranial nerve pain syndromes

Article Title: Theodore H. Weisenburg (1876–1934)

Article References: Triarhou, L. C. (2026). Theodore H. Weisenburg (1876–1934). Journal of Neurology, 273(10), Article 614. https://doi.org/10.1007/s00415-026-14120-5

Image Credits: AI Generated

DOI: 10.1007/s00415-026-14120-5

Keywords: Theodore H. Weisenburg, aphasia, neurology history, glossopharyngeal neuralgia, cerebellar localization, cranial nerves, neuropsychology, Journal of Neurology, Lazaros C. Triarhou, Charles K. Mills memorial lecture, Archives of Neurology and Psychiatry, pioneers in neurology

The toolkit, developed by Allegra Benzini, Alyssa M. Lanzi, Cinzia Palmirotta, Simona Aresta, Petronilla Battista, and Gaia C. Santi of the Istituti Clinici Scientifici Maugeri IRCCS and the University of Delaware, extends the CHAT transcription conventions and the CLAN analysis software developed within the CHILDES/TalkBank framework to Italian-speaking adults with neurological disorders. CHAT—Codes for the Human Analysis of Transcripts—and its companion program CLAN have long been the backbone of quantitative language analysis, implemented in 28 languages and applied to a database of more than 44 million spoken words. Yet the system was originally designed around English child language, and its conventions presuppose English grammar, English phonology, and English clinical presentation. The Italian adaptation, presented as a downloadable operational manual, systematically reshapes those conventions to fit the structure of Italian and the realities of aphasic speech.

The methodological heart of the work is a transparent decision tree applied to every symbol in the CHAT manual. Each of the 59 transcription symbols was evaluated symbol by symbol against explicit inclusion and exclusion criteria: symbols had to be relevant to adult clinical populations and to linguistic phenomena associated with neurologically based language disorders such as post-stroke aphasia, mild cognitive impairment, primary progressive aphasia, Parkinson’s disease, and Alzheimer’s disease. Symbols dedicated to child language development or to conversational analysis notation irrelevant to adult neurological speech were excluded from consideration from the start. The outcome of that evaluation was decisive: 40 symbols were retained unchanged, 15 were removed, four were adapted for Italian, and one was newly created. A parallel process addressed the 11 error-coding symbols, of which six were retained, four were adapted, and one new marker was introduced, with no symbols eliminated outright.

Many of the removals follow directly from the architecture of Italian. As a syllable-timed language, Italian does not systematically encode secondary stress at the lexical level, so the secondary stress marker was dropped. Vowel lengthening, common in Italian and heavily influenced by non-pathological dialectal variation, would confound clinical interpretation, so the lengthened-syllable marker went as well. Punctuation symbols such as the comma, semicolon, and colon were excluded because they neither define units of analysis nor influence automated CLAN outputs such as mean utterance length. The multiple-repetition marker was deemed redundant, already captured by the existing repetition symbol, and the unclear retracing notation was removed because it served only conversion to a competing transcription system. These are small deletions, but together they strip the transcription of artifacts that would otherwise inject noise into quantitative measures of Italian speech.

The adaptations cut deeper. In English, the omission of subjects, auxiliaries, or function words is typically a grammatical violation, so the original CHAT system codes such omissions with an error marker. Italian, however, is a null-subject language: dropping the pronoun in a phrase like “ha gli occhiali da sole”—literally “has the sunglasses”—is perfectly grammatical. The Italian toolkit therefore restricts the omitted-word marker to contexts where omission genuinely violates Italian grammar, and limits the grammatical error marker to utterances whose well-formedness fails by Italian, not English, standards. The clause delimiter was likewise repurposed to tag subordinate clauses, giving clinicians a direct metric of syntactic complexity that the English system computes automatically but that had no Italian equivalent—critical for characterizing the telegraphic, agrammatic output of many aphasic patients.

Phonological error coding underwent a deliberate simplification. The extensive English taxonomy of phonological error subtypes was collapsed into two operational categories: one for recognizable phonological errors such as omissions, substitutions, insertions, and metatheses, and one for phonological neologisms—complete losses of the intended target that may co-occur with non-word transcription symbols. Morphological coding was similarly tailored to the Italian inflectional system, split into markers for agreement errors of gender, number, and person, and for errors of verbal morphology including tense, mood, and irregular inflections. Because Italian verbs carry their grammatical freight in rich inflectional endings rather than in separate auxiliary words, morphological errors reveal a different facet of aphasia in Italian than they do in English.

Two entirely new symbols fill gaps that became glaring in clinical practice. The first, a word fragment marker, captures partial word productions that are abandoned without reformulation and without a precisely recognizable lexical target—a phenomenon the authors note is frequent in adult neurological speech and central to the lexical retrieval difficulties that constitute the most common aphasic disorder. The second, an articulatory distortion marker, codes phonetic distortions in which sounds are mangled despite correct phonological sequencing, a hallmark of motor speech impairments such as apraxia of speech and dysarthria. The original English system could represent such behaviors structurally, but could not quantify them at the error-coding level, even though distinguishing dysarthria from apraxia of speech from phonological difficulty is essential for differential diagnosis in the clinic.

To demonstrate the toolkit’s discriminative power, the researchers applied it to a connected speech sample from a 64-year-old right-handed woman with the non-fluent variant of primary progressive aphasia, a condition defined by effortful, agrammatic, often barely intelligible speech. Her sample, elicited with the picture-description task of the Screening for Aphasia in Neurodegeneration, was transcribed in Italian with the adapted conventions and compared with its English translation transcribed under the original CHAT rules. The side-by-side comparison exposes how the same clinical behavior is encoded differently depending on the language of analysis: the Italian transcript flags articulatory distortions, repeated phonological fragments, and retracing sequences through the new markers, while the English transcript must insert a null subject and assign a grammatical error code to subject omission that is simply licensed grammar in Italian. Compound nouns provide a further illustration, since English compounds rely on hierarchical stress patterns that Italian lexical items, carrying a single primary stress, do not.

Beyond the immediate benefit to Italian clinicians and researchers, the study stakes out a broader claim about how speech analysis should travel across languages. The authors emphasize that the majority of the world’s population does not speak English, yet research and clinical tools remain overwhelmingly Anglophone, and directly transferring English instruments often fails for diagnosis, treatment, and cross-cultural comparison. Their prior cross-linguistic work comparing healthy speakers of English, Italian, Cantonese, and Mandarin found significant differences in function word use and phonology that reflect language-specific morphosyntactic rules, reinforcing the point that linguistic diversity shapes the very manifestation of language processing patterns. The Italian toolkit therefore aims at a balance: preserving the conceptual organization and operational principles of TalkBank so that data remain comparable across languages, while introducing targeted adjustments grounded in the structure of Italian. It is designed as a flexible resource in which users select coding options guided by specific clinical or research goals, whether at the word or sentence level, or across the phonetic–phonological, lexical–semantic, morphosyntactic, and pragmatic domains.

The authors are candid about limitations. The adaptation targets adult speakers with neurological disorders and does not address developmental populations, where further modifications would be needed; coding remains time-consuming and may constrain large-scale implementation; and the morphosyntactic annotation layer—the %mor and %pos tiers—was deliberately left untouched, since adapting it requires alignment with both Italian grammar and specific research hypotheses. Future work, they suggest, should explore tighter integration between standardized coding schemes and automated transcription approaches such as Whisper-based speech recognition. Still, the toolkit stands as a replicable model for extending standardized annotation systems to any structurally distinct language, a necessary step if the rapidly advancing field of speech-based neurological biomarkers is to serve patients in the languages they actually speak.

Subject of Research: Cross-linguistic adaptation of standardized speech transcription and coding tools for assessing neurological language disorders in Italian-speaking adults.

Article Title: Extending standardized speech analysis across languages: An Italian toolkit for transcription and coding of neurological speech

Article References: Benzini, A., Lanzi, A. M., Palmirotta, C., Aresta, S., Battista, P., & Santi, G. C. (2026). Extending standardized speech analysis across languages: An Italian toolkit for transcription and coding of neurological speech. Behavior Research Methods, 58(10), Article 292. https://doi.org/10.3758/s13428-026-03175-x

Image Credits: AI Generated

DOI: 10.3758/s13428-026-03175-x

Keywords: speech analysis, CHAT, CLAN, TalkBank, aphasia, primary progressive aphasia, cross-linguistic adaptation, Italian language, neurodegenerative disease, connected speech, language annotation, behavior research methods

The stakes could hardly be higher. Language impairments arising from aphasia after stroke, developmental language disorders, traumatic brain injury, neurodegenerative conditions such as Parkinson’s disease, and other neurological conditions affect communication in ways that standard speech technology was never designed to handle. Disfluent speech, word-finding pauses, mispronunciations, grammatical breakdowns, and atypical prosody can all scramble the acoustic and statistical patterns that modern recognition systems rely on. When a person with aphasia says a word haltingly or produces a neologism in place of the intended target, a recognition system trained predominantly on fluent, typical adult speech may simply fail, and that failure cascades downstream into every application that depends on accurate transcription.

The architecture of modern speech recognition helps explain why. State-of-the-art systems, including end-to-end neural models trained on tens of thousands of hours of audio, learn to map sound sequences to text by exploiting statistical regularities in their training data. Those regularities include not just phonetics but also the linguistic content of the speech itself. A recognizer hearing a garbled or incomplete utterance leans heavily on language-model priors to guess what was said, essentially autocorrecting toward plausible fluent speech. For typical speakers this bias improves accuracy, but for individuals with language impairments it can systematically distort what they actually said, replacing their intended words with the model’s own statistical expectations and effectively silencing their voice in favor of the algorithm’s prediction.

The research team evaluated how this plays out empirically by testing recognition systems on speech produced by individuals with language impairments and comparing performance against typical speech benchmarks. The results reveal a substantial performance gap. Word error rates climb steeply on impaired speech, and the errors are not randomly distributed: content words, which carry the semantic heart of a message, are disproportionately misrecognized or dropped, while function words are preserved. That asymmetry matters enormously, because a transcript that keeps the grammatical scaffolding but loses the meaningful content is nearly useless both for human readers and for any downstream language model asked to interpret, expand, or respond to the speaker’s intent.

On top of the transcription layer, the study examines large language models as assistive partners, the idea being that a person with aphasia might produce a fragmented utterance, which the recognizer transcribes imperfectly, and which the language model then attempts to repair, expand, or convert into a well-formed communicative act such as a text message or an email. In principle this pipeline could restore independence for people who struggle with everyday written and spoken communication. In practice, the researchers find that the pipeline inherits and sometimes amplifies the weaknesses of each stage. When the recognizer drops a content word, the language model cannot know what is missing, so it fluently completes the sentence with the wrong meaning, producing output that looks polished but betrays the speaker’s actual intent.

This problem of confident error propagation is one of the most consequential findings. Large language models are trained to produce coherent, plausible text, and they apply that objective whether or not the input transcript was accurate. The studies show that models asked to repair impaired-speech transcripts will happily generate grammatical, natural-sounding sentences that diverge from what the speaker meant. For assistive communication, such fluent fabrication is arguably worse than a raw, broken transcript, because conversation partners and caregivers may assume the polished output is trustworthy. The researchers emphasize that any deployed system must therefore build in transparency about uncertainty, letting users verify and correct the interpretation rather than presenting the model’s guess as fact.

Encouragingly, the work also identifies pathways toward improvement. Recognition accuracy for impaired speech improves substantially when systems are adapted, whether through fine-tuning on disordered speech data, personalizing acoustic models to an individual speaker’s voice and error patterns, or injecting contextual information about the communicative setting. Similarly, language models perform better as assistive aids when they are constrained, prompted with information about the speaker’s typical vocabulary and communication goals, or paired with interactive correction loops in which the user can confirm or reject candidate interpretations. These findings suggest that the technology is not fundamentally unsuited to this population, but that off-the-shelf deployment is. Deliberate, user-centered engineering is required to close the gap.

The study also raises important questions about evaluation methodology in the field. Benchmarks that dominate speech technology research contain almost no disordered speech, so headline accuracy figures say little about performance for this population. The authors argue for including individuals with language impairments in dataset collection, reporting performance stratified by speaker characteristics and impairment severity, and evaluating assistive pipelines end to end rather than optimizing transcription accuracy in isolation. A system that achieves slightly worse word error rates but preserves meaning and supports successful repair might serve users far better than one optimized purely for a conventional benchmark metric. Aligning evaluation with real communicative outcomes is presented as a necessary step for the field.

Beyond the technical conclusions, the research lands at a moment of intense public debate about artificial intelligence and accessibility. Voice interfaces are becoming the default way people interact with phones, homes, vehicles, and services, and large language models are being embedded in virtually every communication tool. If these systems systematically fail people with language impairments, the accessibility divide will widen even as technology advances, turning everyday tasks that others take for granted into new barriers. Conversely, if the gaps identified here are addressed through inclusive data, careful system design, and genuine involvement of affected communities, the same technologies could deliver on their long-promised potential: restoring voice, autonomy, and connection to people whose communication abilities have been compromised by injury or disease. The study’s message is ultimately one of cautious optimism grounded in rigor. The tools are powerful, the gaps are measurable, and the solutions are identifiable. What remains is the commitment to build speech and language AI not just for the typical speaker, but for the full diversity of human communication, ensuring that the next generation of voice technology leaves no voice behind.

Subject of Research: Evaluation of automatic speech recognition and large language models for assisting individuals with language impairments

Article Title: Assessing the use of automatic speech recognition and large language models for individuals with language impairments

Article References: Xu, G., Yu, H., Wei, L., Liu, Y., Liu, D., Xu, C., Li, J., Abbasi, A., Xiong, J., Yu, X., Zheng, Z., Shi, Y., & Qin, R. (2026). Assessing the use of automatic speech recognition and large language models for individuals with language impairments. Nature Communications. https://doi.org/10.1038/s41467-026-76677-z

Image Credits: AI Generated

DOI: 10.1038/s41467-026-76677-z

Keywords: automatic speech recognition, large language models, language impairments, aphasia, accessibility, assistive technology, speech recognition accuracy, word error rate, communication disorders, AI bias, inclusive AI, Nature Communications

Mills was born in 1845 and came of age at a moment when the study of the nervous system was undergoing a profound conceptual revolution. The doctrine of cerebral localization, championed in Europe by figures such as Paul Broca and John Hughlings Jackson, was steadily overturning the older view of the brain as an undifferentiated organ. American medicine, however, lagged behind its European counterparts in embracing these ideas, and it fell to a small group of Philadelphia clinicians to translate localization theory into bedside practice. Mills emerged as one of the most forceful American advocates of this new way of thinking, arguing that careful correlation of symptoms with lesions could yield practical guidance for diagnosis and even for surgery.

His early scholarly output reflected this commitment. In 1879, barely into his thirties, Mills published notes on the localization of diseases of the brain, an early demonstration of his conviction that neurology had to be grounded in anatomical precision. He would expand on this theme throughout his career, culminating in his 1889 address on cerebral localization in its practical relations, delivered before the First Triennial Session of the Congress of American Physicians and Surgeons in Washington, DC. That expansive paper, running to a hundred printed pages, laid out the state of the art in localization and argued that the doctrine was not merely an academic curiosity but a working tool for the practicing physician.

Mills was also a clinician-surgeon in an era when operating on the brain was still a daring proposition. In 1891, together with W. W. Keen Jr., one of America’s pioneering surgeons, he reported a landmark case of Jacksonian epilepsy in which trephining was performed, a small tumor was removed, and epileptogenic cortex was excised. The case exemplified the translational power of localization theory: by mapping a patient’s seizures to a specific cortical region, the team could justify an operation that would have been unthinkable under earlier frameworks. Such collaborations between neurologists and surgeons helped establish the intellectual foundations on which modern neurosurgery would later be built.

Perhaps no area of Mills’s work has proven more durable than his contributions to aphasiology. In 1904 he published a substantial treatise in the Journal of the American Medical Association on the treatment of aphasia by training, a remarkably forward-looking document that anticipated modern rehabilitation approaches to language disorders. At a time when aphasia was largely regarded as a fixed deficit to be described and classified, Mills argued that systematic training could produce meaningful recovery in patients with language impairment. His emphasis on therapeutic intervention, rather than passive description, placed him decades ahead of the formal development of speech-language pathology and resonates strongly with contemporary principles of neuroplasticity and rehabilitation medicine.

Mills’s name also survives in the eponymous Mills’ syndrome, a rare clinical entity characterized by progressive ascending hemiplegia without sensory disturbance or dementia. The syndrome has enjoyed a genuine scientific afterlife: a 2019 study in the Journal of Neurology revisited Mills’ syndrome in the light of modern neuroimaging and genetics, examining whether the historical description corresponds to recognizable disease entities such as primary lateral sclerosis or hereditary spastic paraplegia variants. That a clinical picture first delineated in the nineteenth century could prompt a comprehensive re-evaluation in the twenty-first speaks to the descriptive precision that Mills and his contemporaries brought to the neurological examination.

Beyond his individual discoveries, Mills played a crucial institutional role in the professionalization of American neurology. He was a leading figure in the American Neurological Association, and his bibliography, published in the association’s semi-centennial anniversary volume of 1924, documented a scholarly output of extraordinary breadth spanning neuroanatomy, clinical neurology, psychiatry, and medical history. He was among the physicians who recognized that neurologic specialization in America depended not only on clinical skill but on technology, a thesis later explored by historian Douglas Lanska in a 1997 analysis of the role of technology in neurologic specialization. The adoption of instruments and laboratory methods, Lanska argued, helped carve neurology out of general medicine, and Mills was an active participant in that transformation.

Contemporaries remembered Mills as a commanding teacher and a meticulous clinician. Two obituary notices published in 1931, the year of his death, capture the esteem in which he was held. Smith Ely Jelliffe, writing in the Journal of Nervous and Mental Disease, and T. H. Weisenburg, writing in the Archives of Neurology and Psychiatry, both offered appreciations of a man who had spent more than half a century shaping the specialty. Weisenburg’s extended memorial, running to nine pages, surveyed the full range of Mills’s contributions, from cerebral localization and epilepsy surgery to aphasia therapy and the history of medicine. Later generations of scholars, including David Goldblatt and James Kennedy in a 1983 essay in Seminars in Neurology, returned to Mills under the evocative title The all-important matter, underscoring how central his work remained to understanding the development of American neurology.

The new profile by Triarhou appears in the Journal of Neurology as part of its long-running Pioneers in Neurology series, which commemorates the figures whose insights built the modern discipline. Placing Mills in this company is fitting. He practiced at the hinge point between the era of heroic gross localization and the era of laboratory neuroscience, and he understood better than most of his contemporaries that the two had to be joined. His insistence that localization be practical, that therapy be attempted even when prognosis seemed bleak, and that the specialty document its own history gave American neurology a template it still follows. As modern neurology grapples with new questions about brain mapping, rehabilitation, and the integration of technology into clinical practice, the career of Charles K. Mills offers a reminder that these concerns are not new but represent the continuing unfolding of an agenda set more than a century ago by physicians who worked with little more than a hammer, a reflex hammer, and an exacting eye at the bedside.

Subject of Research: Historical profile of neurologist Charles K. Mills (1845–1931) and his pioneering contributions to cerebral localization and American neurology.

Article Title: Charles K. Mills (1845–1931)

Article References: Triarhou, L. C. (2026). Charles K. Mills (1845–1931). Journal of Neurology, 273(10), Article 613. https://doi.org/10.1007/s00415-026-14114-3

Image Credits: AI Generated

DOI: 10.1007/s00415-026-14114-3

Keywords: Charles K. Mills, history of neurology, cerebral localization, aphasia, Mills' syndrome, Jacksonian epilepsy, American Neurological Association, Philadelphia neurology, pioneers in neurology, neurological history, Charles, Mills